Literature DB >> 19900857

Treatment of surgically resectable non-small-cell lung cancer in elderly patients.

Benjamin E Haithcock1, Thomas E Stinchcombe, Mark A Socinski.   

Abstract

Lung cancer is the leading cause of cancer mortality in the United States. The median age of diagnosis is 69 years and the number of elderly patients with lung cancer is expected to increase as this segment of the population increases. This review article describes surgical resection, rationale for adjuvant therapy, and the role of molecular markers in this growing patient population.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19900857     DOI： 10.3816/CLC.2009.n.076

Source DB:  PubMed          Journal:  Clin Lung Cancer        ISSN： 1525-7304            Impact factor:   4.785


  4 in total

1.  Transforming growth factor-β1 and α-smooth muscle actin in stromal fibroblasts are associated with a poor prognosis in patients with clinical stage I-IIIA nonsmall cell lung cancer after curative resection.

Authors:  Yongbing Chen; Li Zou; Yongsheng Zhang; Yuanyuan Chen; Pengfei Xing; Wentao Yang; Feng Li; Xiaoqing Ji; Fengjv Liu; Xueguan Lu
Journal:  Tumour Biol       Date:  2014-04-09

2.  Prognostic significance of twist and N-cadherin expression in NSCLC.

Authors:  Linping Hui; Siyang Zhang; Xinjun Dong; Dali Tian; Zeshi Cui; Xueshan Qiu
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

3.  High p-Smad2 expression in stromal fibroblasts predicts poor survival in patients with clinical stage I to IIIA non-small cell lung cancer.

Authors:  Yongbing Chen; Pengfei Xing; Yuanyuan Chen; Li Zou; Yongsheng Zhang; Feng Li; Xueguan Lu
Journal:  World J Surg Oncol       Date:  2014-11-05       Impact factor: 2.754

4.  Correlations of Twist Expression with Pathological and Computed Tomography (CT) Characteristics and Prognosis of Non-Small Cell Lung Cancer (NSCLC).

Authors:  Feng Duan; Dapeng Hao; Wenjian Xu; Xin Zhong; Tao Luo
Journal:  Med Sci Monit       Date:  2019-02-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.